Critical and chronic care products are the branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring whereas chronic care products refers to medical care products which addresses pre-existing or long term illness, as opposed to acute care which is concerned with diagnosis and treatment of short term or severe illness of brief duration.
As per Robert Wood Johnson Foundation, 2004, the need for better management of chronic conditions is urgent. About 141 million people in the United States were living with one or more chronic conditions in 2010, and this number is projected to increase to 171 million by 2030, when almost every other American will be living with one or more chronic conditions. Unless these chronic conditions are managed effectively and efficiently, the implications of these numbers for morbidity and mortality, workplace productivity, and health care costs in the coming decades will be staggering. For example, one estimate projects that by 2034, the number of people with diabetes will double to 42 million and the related health care spending will triple to $336 billion. Similarly, the American Heart Association projects that by 2030, 40 percent of the U.S. population will have some form of cardiovascular disease and the related health care costs will triple from the current $273 billion to $818 billion. Productivity losses associated with chronic diseases are projected to triple to $3.4 trillion from the current $1.1 trillion.
The critical and chronic care products market is expected to witness a steady growth during the forecast period. The growth of overall health care sector during the forecast period is expected to influence the growth of global critical and chronic care products market. Besides this, the major driving factors for global critical and chronic care products market are population aging and an increase in rate of chronic diseases. Moreover, increase in number of health care facilities across the globe is expected to fuel the growth of global critical and chronic care products. Also, Increase in lifestyle influenced diseases such as coronary heart diseases, along with the growing affluence has resulted in a steady growth in demand for critical and chronic care products. On the flip side, the high cost of these critical and chronic care products can act as an impediment to the growth of global critical and chronic care products market.
The critical and chronic care products market can be segmented by treatment, by devices, by temperature management, by vascular access, by patient care, by blood testing devices, by end-user and by geography. In the terms of treatment, the Critical and chronic care products are classified into surgical, medical, pediatric, psychiatric, burn care, trauma care, myocardial infarction, other intensive care treatment. The trauma care and myocardial infarction comprises the largest market share of the total critical and chronic care products market. Based on the devices, the market is segmented into anesthesia airway: endotracheal tubes, intubation accessories, mechanical ventilation; drainage systems: chest drainage catheters, external ventricular drainage catheters, thoracic kits, wound drainage system; infusion systems: I.V. disposables, syringe infusion pump software, syringe infusion pump systems, large volume I.V. administration sets, volumetric pump accessories; patient monitoring: respiratory monitors, hemodynamic monitors, neuro monitors, cardiac monitors, fetal and neonatal monitors, multi-parameter monitors; pressure monitoring: pressure infusors, pressure monitoring accessories and components, pressure transducer systems; ventilators: non-invasive ventilators and invasive ventilator.
Based on temperature management, the critical and chronic care products market is classified into blood & fluid warming systems, convective warming systems, hyperthermia and hypothermia management devices. Based on vascular access, the market is segmented into, implantable ports and peripheral intra-venous catheters. Similarly based on patient care, market can be segmented as, Level0: normal wound care, Level1: patients with deteriorating conditions who need additional care, Level2: patients with single failing organ system or post- operative care and Level3: patients requiring additional advanced support systems. Based on end-user, the critical and chronic care products can be segmented as, hospitals, ambulatory surgical centers/clinics and rehabilitation centers.
Geographically, North America occupies the largest market share followed by other developed region like Europe. The United States accounts for a major share of the global market. The high awareness level in this region led the market of critical and chronic care products for expansion significantly. However, the same factor of affordability has restrained the markets in developing regions. Despite of this, Asia Pacific has shown striking increase in its growth rate for the critical and chronic care products market. Rising population, increase in disposable income, and increase in awareness level are some key factors driving the Asia Pacific Market. Due to this factors, the Asian market is observing high number of new entrants compared to those in developed regions.
The Major players reported in the market include Abbott Laboratories, Piramal, Mylan, Convatec, Novartis, GE Healthcare, Abbott, Plunkett’s Health Care, Sproxil, Safaricom, Dexcom, Walgreens and Baxter International, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.